This observation is in agreement with recent findings by Marcuello et al (2004) who revealed a significant association between clinical outcome to 5-FU-based chemotherapy in colorectal cancer and TS polymorphisms only if both TS polymorphisms within the 5′ UTR were analysed in conjunction (Marcuello et al, 2004). Here, TYMS is linked to colorectal cancer.